July 2018

Greetings from Synergy Wellness, your source for organically grown, artisanally crafted, small batch, medicinal cannabis products.

Featuring our newest tincture, Synergy Tsu, its benefits for you!
Synergy Tsu: Indica/Sativa CBD hybrid 24:1 CBD:THC
Phenotype of Canna Tsu (aka Canna Sue) with higher CBD:THC ratio.

Synergy Tsu , a higher CBD phenotype of Canna Tsu, originally developed by Lawrence Ringo of SoHum Seeds (Southern Humboldt Seed Company) is the result of crossbreeding Cannatonic and Tsunami parents. It is a favorite of many returning patients because of its medicinal effectiveness. Cannatonic’s popular and complex compounds, unveiled in an indica dominance that is tempered by Sour Tsunami’s sativa dominant soothing qualities, results in uplifting clarity. Overall, it offers some of the best CBD-hybrid options.

Synergy Tsu has many medicinal applications which include treatment of conditions needing higher CBD ratios, such as pain, stress, Chron’s disease, ALS, inflammation, anxiety and cancer. It can be effectively used in an extract form for skin conditions, beauty products and anti-aging cremes. Its high beta-Mycerene content helps with sleep problems and has a relaxing effect. 1

Notably: Synergy Tsu contains a high proportion of an often overlooked cannabinoid,CBDV ( Cannabibvarin ), recently garnering increased attention for its ability to interact with pain receptors in the body, studies of CBDV indicate it is likely Neuroprotective, Anti-emetic, Anti-epileptic, promotes bone growth and regeneration. Other properties remain to be investigated.

In 2014, the Endocannabinoid Research Group in Italy published  a study  in the journal ACS Chemical Neuroscience. Examining the effect of cannabinoids in the treatment of epilepsy and found that both CBD and CBDv play multiple roles in helping reduce and modulate seizure activity. Reported the study’s researchers:

“CBDv reduced both epileptiform burst amplitude and duration.” 2

1 ” CBD a Patient’s Guide to Medicinal Cannabis: Healing Without the High”
by Leonard Leinow & Juliana Birnbaum; Forward by Michael H. Moskowitz, MD
2 https://www.massroots.com/learn/what-is-cbdv-cannabidivarin/


Research Participants Sought: Synergy Wellness is a founding member of MCRCM, the Medicinal Cannabis Research Consortium of Marin. This is a fairly new research group that includes Michael Moskowitz, MD,MPH, AnandaMedicine and the Bay Area Pain Clinic, George Bianchini, M.C. Pharma, Bill Heriot, Lipomix and Leonard Leinow, Synergy Wellness. We have begun a research project to explore the properties of CBDV. This research will ultimately take the form of a clinical trial. We are interviewing subjects for our research project, to help study the medicinal effects of CBDV. If you would like to participate in our study, please contact us: Research@SynergyCBD.com . We are particularly interested if you have neurological or epileptic disorders or imbalances.

CBD a Patient’s Guide to Medicinal Cannabis:
Healing Without the High
by Leonard Leinow & Juliana Birnbaum
Forward by Michael H. Moskowitz, MD

“Medical Cannabis is revolutionizing the practice of medicine in America. On the forefront of that revolution is ‘CBD: A Patient’s Guide to Medical Cannabis’, a must-read for health care practitioners and patients alike.” – Joel Samuels, MD

Order your copy today!

317 Pages ~ US $21.95 / $28.99 CAN

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program.